Taurines, R.; Kunkel, G.; Fekete, S.; Fegert, J.M.; Wewetzer, C.; Correll, C.U.; Holtkamp, K.; Böge, I.; Renner, T.J.; Imgart, H.;
et al. Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine. Pharmaceutics 2024, 16, 772.
https://doi.org/10.3390/pharmaceutics16060772
AMA Style
Taurines R, Kunkel G, Fekete S, Fegert JM, Wewetzer C, Correll CU, Holtkamp K, Böge I, Renner TJ, Imgart H,
et al. Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine. Pharmaceutics. 2024; 16(6):772.
https://doi.org/10.3390/pharmaceutics16060772
Chicago/Turabian Style
Taurines, Regina, Gesa Kunkel, Stefanie Fekete, Jörg M. Fegert, Christoph Wewetzer, Christoph U. Correll, Kristian Holtkamp, Isabel Böge, Tobias Johann Renner, Hartmut Imgart,
and et al. 2024. "Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine" Pharmaceutics 16, no. 6: 772.
https://doi.org/10.3390/pharmaceutics16060772
APA Style
Taurines, R., Kunkel, G., Fekete, S., Fegert, J. M., Wewetzer, C., Correll, C. U., Holtkamp, K., Böge, I., Renner, T. J., Imgart, H., Scherf-Clavel, M., Heuschmann, P., Gerlach, M., Romanos, M., & Egberts, K.
(2024). Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine. Pharmaceutics, 16(6), 772.
https://doi.org/10.3390/pharmaceutics16060772
